196 related articles for article (PubMed ID: 22951844)
1. [A perspective to lipid lowering therapy after ESC/EAS guidelines for the management of dyslipidaemias and the European guidelines on cardiovascular disease prevention in clinical practice].
Ural D
Turk Kardiyol Dern Ars; 2012 Jun; 40(4):293-7. PubMed ID: 22951844
[No Abstract] [Full Text] [Related]
2. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).
; Catapano AL; Reiner Z; De Backer G; Graham I; Taskinen MR; Wiklund O; Agewall S; Alegria E; Chapman MJ; Durrington P; Erdine S; Halcox J; Hobbs R; Kjekshus J; Perrone Filardi P; Riccardi G; Storey RF; Wood D;
Atherosclerosis; 2011 Jul; 217 Suppl 1():S1-44. PubMed ID: 21723445
[No Abstract] [Full Text] [Related]
3. New ESC/EAS Guidelines for the management of dyslipidaemias - any controversies behind the consensus?
Reiner Z
Eur J Cardiovasc Prev Rehabil; 2011 Oct; 18(5):724-7. PubMed ID: 21945917
[No Abstract] [Full Text] [Related]
4. [The new 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk: comparison with the ESC/EAS recommendations for the management of dyslipidemias].
Catapano AL; Averna M; Faggiano P; Novo S
G Ital Cardiol (Rome); 2014 Jan; 15(1):19-20. PubMed ID: 24503730
[No Abstract] [Full Text] [Related]
5. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).
; Reiner Z; Catapano AL; De Backer G; Graham I; Taskinen MR; Wiklund O; Agewall S; Alegria E; Chapman MJ; Durrington P; Erdine S; Halcox J; Hobbs R; Kjekshus J; Filardi PP; Riccardi G; Storey RF; Wood D;
Eur Heart J; 2011 Jul; 32(14):1769-818. PubMed ID: 21712404
[TBL] [Abstract][Full Text] [Related]
6. ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).
Catapano AL; Reiner Z; De Backer G; Graham I; Taskinen MR; Wiklund O; Agewall S; Alegria E; Chapman M; Durrington P; Erdine S; Halcox J; Hobbs R; Kjekshus J; Filardi PP; Riccardi G; Storey RF; Wood D; ;
Atherosclerosis; 2011 Jul; 217(1):3-46. PubMed ID: 21882396
[No Abstract] [Full Text] [Related]
7. The new joint EAS/ESC guidelines for the management of dyslipidaemias.
Catapano AL; Chapman J; Wiklund O; Taskinen MR
Atherosclerosis; 2011 Jul; 217(1):1. PubMed ID: 21722901
[No Abstract] [Full Text] [Related]
8. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias.
Catapano AL; Graham I; De Backer G; Wiklund O; Chapman MJ; Drexel H; Hoes AW; Jennings CS; Landmesser U; Pedersen TR; Reiner Ž; Riccardi G; Taskinen MR; Tokgozoglu L; Verschuren WMM; Vlachopoulos C; Wood DA; Zamorano JL; Cooney MT;
Eur Heart J; 2016 Oct; 37(39):2999-3058. PubMed ID: 27567407
[No Abstract] [Full Text] [Related]
9. [New european guidelines for dyslipidemia].
Riesen WF; Virgini V; Vogt B; Rodondi N
Rev Med Suisse; 2012 Mar; 8(331):525-6, 528-30. PubMed ID: 22471115
[TBL] [Abstract][Full Text] [Related]
10. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias: The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Assocciation for Cardiovascular Prevention & Rehabilitation (EACPR).
; Catapano AL; Graham I; De Backer G; Wiklund O; Chapman MJ; Drexel H; Hoes AW; Jennings CS; Landmesser U; Pedersen TR; Reiner Ž; Riccardi G; Taskinen MR; Tokgozoglu L; Verschuren WM; Vlachopoulos C; Wood DA; Zamorano JL
Atherosclerosis; 2016 Oct; 253():281-344. PubMed ID: 27594540
[No Abstract] [Full Text] [Related]
11. [2016 ESC/EAS Guidelines for the Management of Dyslipidaemias: What is new?].
Kayıkçıoğlu M; Tokgözoğlu L
Turk Kardiyol Dern Ars; 2017 Mar; 45(2):109-112. PubMed ID: 28424431
[No Abstract] [Full Text] [Related]
12. [Opinion of the Czech Atherosclerosis Society's committee (CSAT) on the ESC/EAS guidelines related to the diagnostics and treatment of dyslipidemias issued in 2011].
Soška V; Vaverková H; Vráblík M; Bláha V; Cífková R; Freiberger T; Kraml P; Piťha J; Rosolová H; Stulc T; Urbanová Z
Vnitr Lek; 2013 Feb; 59(2):120-6. PubMed ID: 23461401
[TBL] [Abstract][Full Text] [Related]
13. [2016 ESC/EAS Guidelines for the Management of Dyslipidaemias].
Catapano AL; Graham I; De Backer G; Wiklund O; Chapman MJ; Drexel H; Hoes AW; Jennings CS; Landmesser U; Pedersen TR; Reiner Ž; Riccardi G; Taskinen MR; Tokgozoglu L; Verschuren WM; Vlachopoulos C; Wood DA; Zamorano JL
Kardiol Pol; 2016; 74(11):1234-1318. PubMed ID: 27910077
[No Abstract] [Full Text] [Related]
14. The first European Guidelines focussed on: management of dyslipidaemias.
Taylor J
Eur Heart J; 2011 Aug; 32(16):1949-50. PubMed ID: 21841204
[No Abstract] [Full Text] [Related]
15. Lipid Clinics Network. Rationale and design of the EAS global project.
Alieva AS; Tokgözoğlu L; Ray KK; Catapano AL
Atheroscler Suppl; 2020 Dec; 42():e6-e8. PubMed ID: 33589226
[TBL] [Abstract][Full Text] [Related]
16. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.
Mach F; Baigent C; Catapano AL; Koskinas KC; Casula M; Badimon L; Chapman MJ; De Backer GG; Delgado V; Ference BA; Graham IM; Halliday A; Landmesser U; Mihaylova B; Pedersen TR; Riccardi G; Richter DJ; Sabatine MS; Taskinen MR; Tokgozoglu L; Wiklund O;
Eur Heart J; 2020 Jan; 41(1):111-188. PubMed ID: 31504418
[No Abstract] [Full Text] [Related]
17. [ESC/EAS Guidelines for the management of dyslipidaemias].
Reiner Ž; Catapano AL; De Backer G; Graham I; Taskinen MR; Wiklund O; Agewall S; Alegría E; Chapman MJ; Durrington P; Erdine S; Halcox J; Hobbs RH; Kjekshus JK; Perrone Filardi P; Riccardi G; Storey RF; David W;
Rev Esp Cardiol; 2011 Dec; 64(12):1168.e1-1168.e60. PubMed ID: 22115524
[No Abstract] [Full Text] [Related]
18. [Update on current care guideline: dyslipidaemias].
Duodecim; 2013; 129(11):1198-9. PubMed ID: 23819207
[TBL] [Abstract][Full Text] [Related]
19. The changing landscape of lipid-lowering therapy after the new ESC/EAS guidelines for the management of dyslipidaemias: Launching the era of triple hypolipidaemic therapy in very high risk patients.
Rallidis LS
Atherosclerosis; 2020 Jan; 292():231-233. PubMed ID: 31784033
[No Abstract] [Full Text] [Related]
20. [Comments on the ESC/EAS guidelines for the management of dyslipidaemias 2011. A report of the Task Force of the Clinical Practice Guidelines Committee of the Spanish Society of Cardiology].
Anguita M; Alegría E; Barrios V; Casasnovas JA; Escobar C; León M; Luengo E; Llisterri JL; Alonso Á; Cequier Á; Comín J; Fernández-Ortiz A; Heras M; Pan M; Worner F
Rev Esp Cardiol; 2011 Dec; 64(12):1090-5. PubMed ID: 22107831
[No Abstract] [Full Text] [Related]
[Next] [New Search]
